As the novel coronavirus (COVID-19) continues to spread across the world, our analysts are constantly tracking the impact of this rapidly evolving situation on the markets and the consumer purchase behaviours. Thus, our latest estimates and analysis about the current market trends and forecast will exhaustively reflect the effects of this emerging pandemic.
The global epigenetics market stood at a value of around USD 877 million in 2020. The market is further expected to grow at a CAGR of 13.6% in the forecast period of 2022-2027 to attain a value of USD 1,908 million by 2026.
Based on product, the kits segment holds a significant share in the global epigenetics industry. This growth can be attributed to the important role of kits in the entire epigenetic analysis process. Furthermore, this number is further expected to rise in the forecast period due to the increasing chronic illnesses and the growing geriatric population rates, which is very susceptible to acquiring various diseases, including cardiovascular diseases or cancer.
Read more about this report - REQUEST FREE SAMPLE COPY IN PDF
Meanwhile, the oncology segment is estimated to observe a healthy growth in terms of application due to the high usage of epigenetic research in the oncology field.
North America is predicted to occupy a considerable share of the global epigenetics industry. This surge can be attributed to the increased utilisation of epigenetic research in the region and the increased investments in the development of the healthcare sector. Another factor influencing the market growth is the rising geriatric population in the region, who are susceptible to chronic diseases such as Parkinson’s disease and cancer.
Epigenetics is an emerging scientific area of study that analyses how environmental influences impact the expression of genes. Based on different environmental experiences, genes are activated and deactivated by cells without any change in the underlying DNA structure of the organism and predict which proteins are transcribed. These external environmental stimuli can affect the genes, which could influence diseases. In addition, research has indicated that many human diseases occur due to the interaction between genetic variants and environmental exposure, such as autism, Parkinson’s disease, and breast cancer, among others.
By product, the market is divided into:
Kits are further divided by type into ChIP sequencing kits, bisulfite conversion kits, whole genome amplification kits, 5-hmC & 5-mC analysis kits, and RNA sequencing kits, among others. At the same time, reagents are further segmented by type into antibodies, magnetic beads, histones, buffers, primers, and others. Meanwhile, enzymes are categorised by type into DNA polymerases, DNA ligases, methyltransferases, acetylases, and reverse transcriptase, among others. And instruments are segregated by type into next-generation sequencers, qPCRs, mass spectrometers, sonicators, and others.
On the basis of application, the industry can be categorised into:
Oncology is further divided by type into solid tumours and liquid tumours, whereas non-oncology is segmented by type into metabolic diseases, infectious diseases, inflammatory diseases, cardiovascular diseases, and others.
Based on end use, the market can be segmented into:
The regional markets for the product include North America, Europe, the Asia Pacific, Latin America, and the Middle East and Africa.
According to WHO reports, cardiovascular diseases are the leading cause of death globally, claiming more than 17.9 million lives every year. Cardiovascular diseases are illnesses of heart and blood vessels that are adversely affected by high-risk behaviours such as unhealthy diet, physical inactivity, and substance abuse. In this regard, epigenetic research has found epigenetic biomarkers, a promising tool for the diagnosis and prognosis of many cardiovascular diseases. Some of their promising features include easy accessibility and feasibility in their detection methods, making them applicable for use in clinical interventions. This is significantly contributing to the growth of the market.
In a 2017 research by the American Diabetes Association, the researchers concluded that diabetes is a complication developed from the interaction of DNA structure variation and the environmental stimuli that causes changes in the cellular phenotype.
The report gives a detailed analysis of the following key players in the global epigenetics market, covering their competitive landscape, capacity, and latest developments like mergers, acquisitions, and investments, expansions of capacity, and plant turnarounds:
The comprehensive EMR report provides an in-depth assessment of the industry based on the Porter's five forces model and SWOT analysis.
|Scope of the Report||Historical and Forecast Trends, Industry Drivers and Constraints, Historical and Forecast Market Analysis by Segment- Product, Application, End Use, Region|
|Breakup by Product||Kits, Reagents, Enzymes, Instruments|
|Breakup by Application||Oncology, Non-Oncology|
|Breakup by End Use||Academic and Research Institutes, Pharmaceutical and Biotechnology Companies, Contract Research Organisations|
|Breakup by Region||North America, Europe, Asia Pacific, Latin America, Middle East and Africa|
|Market Dynamics||SWOT, Porter's Five Forces, EMR’s Key Indicators for Price and Demand|
|Competitive Landscape||Market Structure, Company Profiles- Company Overview, Product Portfolio, Demographic Reach and Achievements, Certifications|
|Companies Covered||Abcam Plc, Active Motif, Inc., Agilent Technologies, Inc., Diagenode S.A., QIAGEN GmbH, Others|
|Report Price and Purchase Option||Explore our purchase options that are best suited to your resources and industry needs.|
|Delivery Format||Delivered as an attached PDF and Excel through email, with an option of receiving an editable PPT, according to the purchase option.|
*We at Expert Market Research always thrive to give you the latest information. The numbers in the article are only indicative and may be different from the actual report.
2 Report Coverage – Key Segmentation and Scope
3 Report Description
3.1 Market Definition and Outlook
3.2 Properties and Applications
3.3 Market Analysis
3.4 Key Players
4 Key Assumptions
5 Executive Summary
5.2 Key Drivers
5.3 Key Developments
5.4 Competitive Structure
5.5 Key Industrial Trends
7 Industry Opportunities and Challenges
8 Global Epigenetics Market Analysis
8.1 Key Industry Highlights
8.2 Global Epigenetics Historical Market (2017-2021)
8.3 Global Epigenetics Market Forecast (2022-2027)
8.4 Global Epigenetics Market by Product
18.104.22.168 Market Share
22.214.171.124 Historical Trend (2017-2021)
126.96.36.199 Forecast Trend (2022-2027)
188.8.131.52 Breakup by Type
184.108.40.206.1 ChIP Sequencing Kits
220.127.116.11.2 Bisulfite Conversion Kits
18.104.22.168.3 Whole Genome Amplification Kits
22.214.171.124.4 5-hmC & 5-mC Analysis Kits
126.96.36.199.5 RNA Sequencing Kits
188.8.131.52 Market Share
184.108.40.206 Historical Trend (2017-2021)
220.127.116.11 Forecast Trend (2022-2027)
18.104.22.168 Breakup by Type
22.214.171.124.2 Magnetic Beads
126.96.36.199 Market Share
188.8.131.52 Historical Trend (2017-2021)
184.108.40.206 Forecast Trend (2022-2027)
220.127.116.11 Breakup by Type
18.104.22.168.1 DNA Polymerases
22.214.171.124.2 DNA Ligases
126.96.36.199.5 Reverse Transcriptase
188.8.131.52 Market Share
184.108.40.206 Historical Trend (2017-2021)
220.127.116.11 Forecast Trend (2022-2027)
18.104.22.168 Breakup by Type
22.214.171.124.1 Next generation sequencers
126.96.36.199.3 Mass Spectrometers
8.5 Global Epigenetics Market by Application
188.8.131.52 Market Share
184.108.40.206 Historical Trend (2017-2021)
220.127.116.11 Forecast Trend (2022-2027)
18.104.22.168 Breakup by Type
22.214.171.124.1 Solid Tumors
126.96.36.199.2 Liquid Tumors
188.8.131.52 Market Share
184.108.40.206 Historical Trend (2017-2021)
220.127.116.11 Forecast Trend (2022-2027)
18.104.22.168 Breakup by Type
22.214.171.124.1 Metabolic Diseases
126.96.36.199.2 Infectious Diseases
188.8.131.52.3 Inflammatory Diseases
184.108.40.206.4 Cardiovascular Diseases
8.6 Global Epigenetics Market by End Use
8.6.1 Academic and Research Institutes
220.127.116.11 Market Share
18.104.22.168 Historical Trend (2017-2021)
22.214.171.124 Forecast Trend (2022-2027)
8.6.2 Pharmaceutical and Biotechnology Companies
126.96.36.199 Market Share
188.8.131.52 Historical Trend (2017-2021)
184.108.40.206 Forecast Trend (2022-2027)
8.6.3 Contract Research Organisations
220.127.116.11 Market Share
18.104.22.168 Historical Trend (2017-2021)
22.214.171.124 Forecast Trend (2022-2027)
8.7 Global Epigenetics Market by Region
8.7.1 Market Share
126.96.36.199 North America
188.8.131.52 Asia Pacific
184.108.40.206 Latin America
220.127.116.11 Middle East and Africa
9 Regional Analysis
9.1 North America
9.1.1 Historical Trend (2017-2021)
9.1.2 Forecast Trend (2022-2027)
9.1.3 Breakup by Country
18.104.22.168 United States of America
9.2.1 Historical Trend (2017-2021)
9.2.2 Forecast Trend (2022-2027)
9.2.3 Breakup by Country
22.214.171.124 United Kingdom
9.3 Asia Pacific
9.3.1 Historical Trend (2017-2021)
9.3.2 Forecast Trend (2022-2027)
9.3.3 Breakup by Country
9.4 Latin America
9.4.1 Historical Trend (2017-2021)
9.4.2 Forecast Trend (2022-2027)
9.4.3 Breakup by Country
9.5 Middle East and Africa
9.5.1 Historical Trend (2017-2021)
9.5.2 Forecast Trend (2022-2027)
9.5.3 Breakup by Country
126.96.36.199 Saudi Arabia
188.8.131.52 United Arab Emirates
184.108.40.206 South Africa
10 Market Dynamics
10.1 SWOT Analysis
10.2 Porter’s Five Forces Analysis
10.2.1 Supplier’s Power
10.2.2 Buyers Power
10.2.3 Threat of New Entrants
10.2.4 Degree of Rivalry
10.2.5 Threat of Substitutes
10.3 EMR’s Key Indicators for Demand
10.4 EMR’s Key Indicators for Price
11 Competitive Landscape
11.1 Market Structure
11.2 Company Profiles
11.2.1 Abcam Plc
220.127.116.11 Company Overview
18.104.22.168 Product Portfolio
22.214.171.124 Demographic Reach and Achievements
11.2.2 Active Motif, Inc.
126.96.36.199 Company Overview
188.8.131.52 Product Portfolio
184.108.40.206 Demographic Reach and Achievements
11.2.3 Agilent Technologies, Inc.
220.127.116.11 Company Overview
18.104.22.168 Product Portfolio
22.214.171.124 Demographic Reach and Achievements
11.2.4 Diagenode S.A.
126.96.36.199 Company Overview
188.8.131.52 Product Portfolio
184.108.40.206 Demographic Reach and Achievements
11.2.5 QIAGEN GmbH
220.127.116.11 Company Overview
18.104.22.168 Product Portfolio
22.214.171.124 Demographic Reach and Achievements
12 Industry Events and Developments
List of Figures and Tables
1. Global Epigenetics Market: Key Industry Highlights, 2016 and 2026
2. Global Epigenetics Historical Market: Breakup by Product (USD Million), 2017-2021
3. Global Epigenetics Market Forecast: Breakup by Product (USD Million), 2022-2027
4. Global Epigenetics Historical Market: Breakup by Application (USD Million), 2017-2021
5. Global Epigenetics Market Forecast: Breakup by Application (USD Million), 2022-2027
6. Global Epigenetics Historical Market: Breakup by End Use (USD Million), 2017-2021
7. Global Epigenetics Market Forecast: Breakup by End Use (USD Million), 2022-2027
8. Global Epigenetics Historical Market: Breakup by Region (USD Million), 2017-2021
9. Global Epigenetics Market Forecast: Breakup by Region (USD Million), 2022-2027
10. North America Epigenetics Historical Market: Breakup by Country (USD Million), 2017-2021
11. North America Epigenetics Market Forecast: Breakup by Country (USD Million), 2022-2027
12. Europe Epigenetics Historical Market: Breakup by Country (USD Million), 2017-2021
13. Europe Epigenetics Market Forecast: Breakup by Country (USD Million), 2022-2027
14. Asia Pacific Epigenetics Historical Market: Breakup by Country (USD Million), 2017-2021
15. Asia Pacific Epigenetics Market Forecast: Breakup by Country (USD Million), 2022-2027
16. Latin America Epigenetics Historical Market: Breakup by Country (USD Million), 2017-2021
17. Latin America Epigenetics Market Forecast: Breakup by Country (USD Million), 2022-2027
18. Middle East and Africa Epigenetics Historical Market: Breakup by Country (USD Million), 2017-2021
19. Middle East and Africa Epigenetics Market Forecast: Breakup by Country (USD Million), 2022-2027
20. Global Epigenetics Market Structure
In 2020, the global epigenetics market attained a value of nearly USD 877 million.
The market is projected to grow at a CAGR of 13.6% between 2022 and 2027.
The major drivers of the industry such as increased investment in the research and development of epigenetic interventions, increasing chronic illnesses, increased application of epigenetic analysis mechanisms in the oncology field, and rising ageing population globally are expected to aid the market growth.
The key market trends guiding the industry's growth include the increasing incidences of cardiovascular diseases and increased utilisation of epigenetic research.
The major regions in the industry are North America, Latin America, the Middle East and Africa, Europe, and the Asia Pacific.
The significant product segments can be divided into kits, reagents, enzymes, and instruments.
The significant applications of the product include oncology and non-oncology. The oncology segment is further divided by type into solid tumours and liquid tumours, whereas non-oncology is distributed by type into metabolic disease, infectious diseases, inflammatory diseases, and cardiovascular diseases, among others.
The major segments based on end-use include academics and research institutes, pharmaceutical and biotechnology companies, and contract research organisations.
The major players in the industry are Abcam Plc, Active Motif, Inc., Agilent Technologies, Inc., Diagenode S.A., and QIAGEN GmbH, among others.
The global epigenetics market attained a value of USD 877 million in 2020, driven by the growing incidences of cardiovascular diseases globally. Aided by the rapidly growing geriatric population and the technological advancements, the market is expected to witness a further growth in the forecast period of 2022-2027, growing at a CAGR of 13.6%.
EMR’s meticulous research methodology delves deep into the market, covering the macro and micro aspects of the industry. By products, the market can be distributed into kits, reagents, enzymes, and instruments. On the basis of applications, the industry can be segmented into oncology and non-oncology. Among this oncology is further divided by type into solid tumours and liquid tumours, whereas non-oncology is distributed by type into metabolic disease, infectious diseases, inflammatory diseases, and cardiovascular diseases, among others. Based on end-use, the market can be categorised into academics and research institutes, pharmaceutical and biotechnology companies, and contract research organisations. The major regional markets for epigenetics market are North America, Europe, the Asia Pacific, Latin America, and the Middle East and Africa. The key players in the above market include Abcam Plc, Active Motif, Inc., Agilent Technologies, Inc., Diagenode S.A., and QIAGEN GmbH, among others.
EMR’s research methodology uses a combination of cutting-edge analytical tools and the expertise of their highly accomplished team, thus, providing their customers with market insights that are accurate, actionable, and help them remain ahead of their competition.
Single User License
Five User License
We are technically excellent, strategic, practical, experienced and efficient; our analysts are hand-picked based on having the right attributes to work successfully and execute projects based on your expectations.
We leverage our cutting-edge technology, our access to trusted databases, and our knowledge of the current models used in the market to deliver you research solutions that are tailored to your needs and put you ahead of the curve.
We deliver in-depth and superior quality research in prices that are reasonable, unmatchable, and shows our understanding of your resource structure. We, additionally, offer attractive discounts on our upcoming reports.
Our team of expert analysts are at your beck and call to deliver you optimum results that are customised to meet your precise needs within the specified timeframe and help you form a better understanding of the industry.